PROPOSITION 61 was a California ballot proposition that appeared on the November 8, 2016 ballot. It would have prohibited the state of California from buying any prescription drug from a drug manufacturer at price over the lowest price paid for the drug by the United States Department of Veterans Affairs. It would have exempted managed care programs funded through Medi-Cal.[1] According to the fiscal impact statement issued by California Legislative Analyst's Office, "potential for state savings of an unknown amount depending on (1) how the measureâ€™s implementation challenges are addressed and (2) the responses of drug manufacturers regarding the provision and pricing of their drugs." [2]
